787.F 14.02 (-0.85%)
PLSLVCR00029Medical Diagnostics & ResearchDiagnostics & Research

Selvita (787.F) Competitor Comparison

We are evaluating the key criteria listed to compare Selvita (787.F) against its competitors in the Diagnostics & Research industry.

Performance 3 years - 787.F ranking 0 / 58

These are the competitors of Selvita in the industry Diagnostics & Research ranked by performance 3 years
1. Lantheus Holdings LNTH
386.61
2. Meridian Bioscience VIVO
246.63
3. RadNet RDNT
139.16
4. Medpace Holdings MEDP
91.27
5. Heska HSKA
41.31
6. PerkinElmer PKI
21.19
7. Ortho Clinical Diagnostics Holdings OCDX
13.74
8. Natera NTRA
10.81
9. Icon ICLR
8.23
10. Quest Diagnostics DGX
5.21
11. Thermo Fisher Scientific TMO
3.11
12. Danaher DHR
2.79
13. Waters WAT
1.23
14. Mettler-Toledo MTD
-2.95
15. IQVIA Holdings IQV
-4.68
16. Bioventus BVS
-4.92
17. Laboratory Corp of America Holdings LH
-7.29
18. Agilent Technologies A
-9.63
19. Qiagen QGEN
-17.04
20. Syneos Health SYNH
-19.01
21. Olink Holding OLK
-22.2
22. Myriad Genetics MYGN
-25.27
23. Exact Sciences EXAS
-26.86
24. IDEXX Laboratories IDXX
-27.45
25. Sera Prognostics SERA
-27.64
26. Anixa Biosciences ANIX
-31.9
27. Sotera Health SHC
-38.63
28. DexCom DXCM
-46.07
29. Charles River Laboratories CRL
-50.88
30. National Research NRC
-53.54
31. Twist Bioscience TWST
-58.05
32. Illumina ILMN
-63.29
33. Neogen NEOG
-64.5
34. MaxCyte MXCT
-65.35
35. CareDx CDNA
-66.19
36. Interpace Biosciences IDXG
-66.67
37. Global Cord Blood CO
-67.25
38. NeoGenomics NEO
-68.47
39. Enzo Biochem ENZ
-69.41
40. Psychemedics PMD
-72.05
41. Fulgent Genetics FLGT
-74.47
42. Personalis PSNL
-75.35
43. Exagen XGN
-76.96
44. Biodesix BDSX
-78.18
45. Guardant Health GH
-78.74
46. bioAffinity Technologies BIAF
-83.21
47. Trinity Biotech TRIB
-83.4
48. MDxHealth MDXH
-83.54
49. Co-Diagnostics CODX
-84.94
50. Precipio PRPO
-87.4
51. Organovo Holdings ONVO
-89.19
52. Neuronetics STIM
-91.07
53. Pacific Biosciences of California PACB
-91.75
54. DarioHealth DRIO
-93.77
55. Inotiv NOTV
-94.96
56. Prenetics Global PRE
-95.56
57. SeqLL SQL
-95.69
58. Aspira Womens Health AWH
-98.83

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.